Back to search results

Screening and Evaluation for NIDA IRP Studies on Substance Use Disorders

This study, called the Screening, Evaluation and Assessment (SEA) Protocol, is looking for people aged 18 to 99 years old, with or without a history of substance use disorder (SUD) or alcohol use disorder (AUD). The main goal is to conduct an initial health and general evaluation to see if you might be a good fit for other research studies at the National Institute on Drug Abuse (NIDA) in Baltimore, MD. These NIDA studies aim to understand why people use drugs, stop using them, or never become addicted, and to develop new treatments for SUDs. This is an observational study, meaning researchers will gather information without giving any specific treatments. The study is currently recruiting a large number of participants.

Study design
This is an observational study with a planned enrollment of 10,000 participants. It is not specified if it is randomized or blinded.
What's involved
You would participate in one or more visits for a clinical and general evaluation.
Compensation
Not stated in the trial record.
Follow-up
Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06552741

Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP

Recruiting
Not specifiedAges 18–99Observational
National Institute on Drug Abuse (NIDA)
~10,000 participants
Updated 2026-08-24 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
To provide an initial clinical and general evaluation of participants to assess eligibility for potential inclusion into other clinical research protocols at the NIDA IRP.
Measured over One or more visits

Conditions

Substance Use Disorder
Alcohol Use Disorder

Explore related trials

Alcohol use disorderSubstance use disorder

Where it's being run

1 sites across 1 states
Maryland1

Study leadership

  • Lorenzo Leggio, M.D. · PRINCIPAL_INVESTIGATOR · National Institute on Drug Abuse (NIDA)

Who to contact

Shannon M Pfistner
[email protected]
(800) 535-8254
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 18-99 years old.
Proficient ability to read, write, and understand English.
Stated willingness to comply with all screening procedures and availability for the duration of the screening period
Ability of subject to understand and the willingness to sign a written informed consent document.

What this trial measures

  • To provide an initial clinical and general evaluation of participants to assess eligibility for potential inclusion into other clinical research protocols at the NIDA IRP.One or more visits

    To screen participants for clinical research protocols and reduce variability as well as the burden of providing the same samples and data more than once (i.e., in screening and then again in the research protocol); Eligibility for clinical research protocols can only be determined once screening requirements for a clinical research protocol(s) are completed.